Regulation of S. aureus pathogenesis via TRAP · 16/10/2000 · Regulation of S. aureus...
Transcript of Regulation of S. aureus pathogenesis via TRAP · 16/10/2000 · Regulation of S. aureus...
Regulation of S. aureus pathogenesis via TRAP
Author list in alphabetical order:
Naomi Balaban1,2,* Tzipora Goldkorn3, Yael Gov2, Miriam Hirshberg4, Nir Koyfman2 Harry R. Matthews5, Rachael T.
Nhan1, Baljit Singh1, Orit Uziel2
1. Department of Pathology, University of California, Davis, Medical Center, Davis, CA 95616, U.S.A.
2. Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3. Department of Internal Medicine, University of California, Davis, CA 95616, U.S.A.
4. Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Old Addenbrooke’s Site, Cambridge CB2
1GA, UK.
5. Department of Biological Chemistry, University of California, Davis, Davis, CA 95616, U.S.A.
*Corresponding author
Send correspondence to: Dr. Naomi Balaban, Department of Pathology, Research Bldg. 3, University of California Davis,
Medical center, Sacramento, CA 95817, USA. Tel. 916-734-3218. Fax 916-734-2698. Email: [email protected]
Running Title = Regulation of Pathogenesis
1
Copyright 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
JBC Papers in Press. Published on October 16, 2000 as Manuscript M005446200 by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
by guest on M
arch 31, 2020http://w
ww
.jbc.org/D
ownloaded from
SUMMARY
Staphylococcus aureus can cause disease through the production of toxins. Toxin production is autoinduced by the protein
RNAIII activating protein (RAP) and by the autoinducing peptide (AIP), and is inhibited by RNAIII inhibiting peptide (RIP)
and by inhibitory AIPs. RAP has been shown to be a useful vaccine target molecule, and RIP and inhibitory AIPs as
therapeutic molecules to prevent and suppress S. aureus infections. Development of therapeutic strategies based on these
molecules has been hindered by a lack of knowledge of the molecular mechanisms by which they activate or inhibit
virulence. Here we show that RAP specifically induces the phosphorylation of a novel 21kDa protein while RIP inhibits its
phosphorylation. This protein was termed TRAP, for “target of RAP”. The synthesis of the virulence regulatory molecule,
RNAIII, is not activated by RAP in the trap mutant strain, suggesting that RAP activates RNAIII synthesis via TRAP.
Phosphoamino acid analysis shows that TRAP is histidine phosphorylated, suggesting that TRAP may be a sensor of RAP.
AIPs upregulate the synthesis of RNAIII also in trap mutant strains, suggesting that TRAP and AIPs activate RNAIII
synthesis via distinct signal transduction pathways. Furthermore, TRAP phosphorylation is downregulated in the presence of
AIP, suggesting that a network of signal transduction pathways regulate S. aureus pathogenesis.
2
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
INTRODUCTION
Staphylococcus aureus is a gram-positive bacteria that can cause many different types of diseases, ranging from minor skin
infections to pneumonia, endocarditis, and toxin shock syndrome (1). Many of the diseases caused by S. aureus have been
associated with the toxins the bacteria produce (2,3,4). Toxic exomolecules include proteases, hemolysins, enterotoxins and
toxic shock syndrome toxin (TSST-1) (1) that not only cause disease but also contribute to the survival of the bacteria in the
host (5).
In culture, the bacteria produce toxic exomolecules only when in higher densities, at the post exponential phase of growth. In
the early exponential phase, when in lower densities, the bacteria express surface molecules such as fibronectin binding-
proteins and fibrinogen binding-protein that allow the bacteria to adhere to and colonize host cells. The ability of the bacteria
to switch between expression of surface adhesion molecules and toxin exomolecules (1) is regulated primarily by an RNA
molecule termed RNAIII (6,7,8). It is hypothesized that it enables the bacteria to adhere to host cells when in low numbers,
but to disengage and spread when too crowded, thus allowing dissemination and establishment of the infection.
RNAIII is encoded by the agr locus (6) and regulates at least 15 genes coding for potential virulence factors. agr mutants are
non pathogenic and show a decreased synthesis of extracellular toxins and enzymes, such as alpha-, beta-, and delta-
hemolysin, leucocidin, lipase, hyaluronate lyase, and proteases, and at the same time an increased synthesis of adhesion
molecules, coagulase and protein A (2,9). The agr locus contains two divergent transcription units, RNAII and RNAIII,
driven by the promoters P2 and P3, both of which are active only from the mid exponential phase of growth (9). RNAII
contains four open reading frames (ORFs): agrA, agrB, agrC, and agrD. The agrA and agrC genes encode a classical two-
component signal transduction pathway composed of the AgrC signal receptor and the AgrA response regulator. The agrD
gene product is a propeptide that is processed and secreted through AgrB, which is an integral membrane protein. The
resultant mature autoinducing peptide (AIP) (10) is the ligand that binds to and activates the phosphorylation of AgrC (11),
which in turn is thought to phosphorylate AgrA, leading to upregulation of RNAIII synthesis (12).
The synthesis of RNAIII is regulated by a quorum sensing mechanism (13). Molecules produced and secreted by the bacteria
(autoinducers) accumulate, and when they reach a threshold concentration, RNAIII is synthesized. The autoinducers of
3
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
RNAIII that have been described to-date are the RNAIII activating protein (RAP) (14,15,16) and the agr-encoded
autoinducing peptides (AIPs) (10,17,18). RAP is a ~38kDa protein containing an NH2-terminal sequence IKKYKPITN
(GenBank AF205220) (16). The AIPs are octapeptides encoded by the agr, are processed from AgrD, and activate RNAIII by
inducing the phosphorylation of their receptor AgrC. Interestingly, AIPs produced by some S. aureus strains inhibit the
expression of agr in other strains, and the amino acid sequences of peptide and receptor (AgrC) are markedly different
between such strains, suggesting a hypervariability-generating mechanism (18). Biochemical analysis of AIPs has suggested
that they contain an unusual thiol ester-linked cyclic structure, which is absolutely necessary for full biological activity (10).
RNAIII synthesis can be inhibited by antibodies directed against RAP. Mice vaccinated with RAP were shown to be
protected from a S. aureus infection. The protection level correlated with the titer of anti-RAP antibodies, suggesting that
RAP is a promising vaccine candidate (15). RNAIII synthesis can be inhibited by AIPs of non-self (10,18), and by RNAIII
inhibiting peptide (RIP) (14,15,16,20). The RIP peptide is produced by coagulase negative staphylococcus (suggested to be
S. warnerii or S. xylosus) (16,19) and has the sequence YSPXTNF, where X can be a cysteine, a tryptophan, or a modified
amino acid. Both native RIP and a synthetic analogue YSPWTNF are extremely effective in inhibiting RNAIII synthesis in
vitro and in suppressing S. aureus infections in vivo (15,20). RIP (native or synthetic) has been shown to prevent S. aureus
SD cellulitis in mice (15). Synthetic RIP has been shown to prevent keratitis (tested in rabbits against S. aureus 8325-4),
osteomyelitis (tested in rabbits against S. aureus MS), mastitis (tested in cows against S. aureus Newbould 305, AE-1, and
environmental infections) and septic arthritis (tested in mice against S. aureus LS-1) (20). These findings strongly evidence
the potential value of RIP as a therapeutic agent. The therapeutic potential of inhibiting RNAIII synthesis was confirmed by
Mayville et al. (10), where it was demonstrated that peptides (AIPs) that inhibit RNAIII synthesis in vitro do in fact inhibit S.
aureus infections in vivo.
Whereas the therapeutic potential of RAP, RIP and inhibitory AIPs is not in dispute, many questions remain unanswered and
hinder the development of vaccines and therapeutics. These include understanding the detailed mechanism by which RAP,
RIP and AIPs regulate RNAIII synthesis; the precise mutual interactions between RAP, RIP and AIPs and the signal
transduction pathway that leads to RNAIII synthesis and concludes in virulence.
4
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
Because of the sequence similarity between the NH2- terminal sequence of RAP and RIP (YKPITN as compared to
YSPXTN), and because RIP has been shown to compete with RAP on the activation of RNAIII synthesis, we hypothesized
that RAP and RIP may bind to the same receptor, one as an agonist (RAP) and the other as an antagonist (RIP). To test for
this hypothesis, RIP derivatives were synthesized according to the putative NH2-terminal sequence of RAP and tested for
their ability to inhibit RNAIII synthesis in vitro and for their ability to prevent S. aureus cellulitis in vivo. The results of these
experiments indicate that the peptides most successful in inhibiting RNAIII synthesis and cellulitis were those that most
resembled the NH2-terminal of RAP and contained the sequence YKPITN (16). These results further suggest that RAP and
RIP may in fact act as an agonist (RAP) and an antagonist (RIP) to the same receptor.
Here we show that RAP activates and RIP inhibits the phosphorylation of a 21kDa protein. We termed this protein TRAP, for
“target of RAP”. Amino acid sequence analysis of TRAP indicates that it is a 167 amino acid polypeptide that is unique to S.
aureus. RAP does not activate RNAIII synthesis in a trap– mutant, suggesting that RAP activates RNAIII synthesis via
TRAP. We also show here that the phosphorylation of TRAP is inhibited by AIP of self, which uses the agr signal
transduction system to activate RNAIII synthesis. Taken together, our results indicate that the trap and the agr signal
transduction systems interact with one another, resulting in upregulation of RNAIII synthesis and in a coordinated production
of virulence factors.
EXPERIMENTAL PROCEDURES
Bacterial strains
Wild type S. aureus strain RN6390B (ATCC 55620). agr-null S. aureus mutant strain RN6911 (6). RIP-producing,
coagulase negative Staphylococcus strain RN833 (ATCC 55619) (14,15,16,19). S. aureus strain RN4220, a mutant of the
wild type S. aureus strain 8325-4 that is capable of accepting foreign DNA (21). S. aureus strain OU20, containing a
disrupted trap, grown at 42oC in the presence of 10µg/ml erythromycin. Unless mentioned otherwise, all bacteria were grown
in CY broth supplemented with β-glycerophosphate (21) at 37oC with shaking from early exponential phase of growth.
5
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
Preparation of RAP
To purify RAP, RN6390B cells were grown to the post exponential phase of growth. Growth culture was centrifuged at 6,000
xg for 10 minutes at 4oC. The supernatant was collected and filtered through a 0.22µm filter to remove residual cells. The
supernatant was lyophilized (FlexiDry MP Lyophilizer) and resuspended in water to a tenth of the original volume (total
10x). 15ml of 10x supernatant was applied to a 10kDa cutoff membrane (Centriprep 10 (Amicon)). This enabled us both to
concentrate the material further and to remove material which is smaller than 10kDa. 1ml concentrated material greater than
10kDa was washed twice in PBS by resuspending it in 15ml PBS and re-concentrating it on the Centriprep 10 and the
material greater than 10kDa collected (>10), which is usually at a 25x-40x concentration. This material contains no AIP and
was used for RAP/RIP or RAP/AIP competition assays (see below) as well as for the further purification of RAP. To further
purify RAP, 600 µl of >10 were fractionated on a gel filtration FPLC column (Superose 12, Pharmacia) in 1mM phosphate
buffered saline pH 7.2 (0.1x PBS), at a flow rate of 0.5 ml/min, and 1ml fractions collected. Fractions were concentrated to a
tenth of their original volume by lyophilization and tested for RNAIII by northern blotting, as described below. Active gel
filtration fraction (1ml) was collected and RAP was further purified by anion exchange chromatography (HPLC SynchroPak
Q300, Keystone Scientific, Inc.) in water pH 7.2. Bound material was eluted by a salt gradient of 0-1M NaCl in water in 1ml
fractions. 38kDa RAP eluted at 0.75M NaCl. Active fraction was lyophilized and resuspended in 100µl water (10x active
fraction, or RAP). To test for activity, 50µl 10x active fraction (RAP) was applied to 450µl early exponential cells (containing
about 2x109 cells) which prepared as described below, in vivo phosphorylation assays.
Preparation of AIP and RIP
To partially purify AIP from RN6390B post exponential culture supernatants or native RIP from RN833 post exponential
supernatants, cells were grown to the post exponential phase of growth. Growth culture was centrifuged at 6,000 xg for 10
minutes at 4oC. The supernatant was collected and filtered through a 0.22µm filter to remove residual cells. The supernatant
was lyophilized (FlexiDry MP Lyophilizer) and resuspended in water to a tenth of the original volume. 15ml of 10x
concentrated supernatant was applied to a 3kDa cutoff membrane (Centriprep 10 (Amicon)) and material smaller than 3kDa
(flow through) was collected and used to test for activity. To test for activity, 50µl of the flow through was applied to 450µl
early exponential cells (containing about 2x109 cells) which prepared as described below, in vivo phosphorylation assays or
6
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
activation of RNAIII synthesis.
In vivo Phosphorylation Assays
S. aureus RN6390B cells (4ml) were grown in CY/GP from lag phase of growth (OD650 of 0.03) until early exponential
phase of growth of OD650 of about 0.2 (equivalent to about 1x109 cells/ml). Cells were collected by centrifugation at
3000xg for 30 minutes or 2min at 12,000xg. Supernatants were discarded and cell pellet was resuspended in 0.9ml phosphate
free buffer (PFB, 20mM KCL, 80mM NaCl, 20mM NH4Cl, 0.14mM Na2SO4, 100mM Tris pH 7.4, 2.5mM MgCl2, 0.1mM
CaCl2, 2µM FeCl2, 0.4% glucose, 9µg/ml thiamine, 0.8mM potassium phosphate buffer pH 7.4, 0.25mM L-arginine,
0.21mM L-histidine, 0.62mM L-lysine, 0.13mM L-glutamic acid, 0.056mM glycine, 0.32mM L-alanine, 0.46mM L-
valine, 0.36mM L-isoleucine, 0.82mM L proline, 0.016mM L-phenylalanine, 0.50mM L-serine, 0.34mM L-threonine,
0.016mM L-tyrosine, L-0.27mM cystein, 0.21mM L-methionine, 0.13mM L-asparagine, 0.029mM Nicotinic acid.
0.13mM L-glutamine) and 28µCi radiolabeled orthophosphate (32P) (ICN Biochemicals). Cells were grown with shaking for
40 min at 37oC in the presence of the following material (prepared as described above): 50µl of total post exponential
supernatant (total 10x, containing 80% AIP and 20% RAP (16)), 50µl AIP, 50µl RAP, 50µl native RIP, with synthetic RIP
(10µg RIP/4x106 cells) or with 50µl control buffer. For growth phase experiments, cells in PFB and 32P were grown for the
times indicated. Cells were collected by centrifugation for 2min 12,000 x g, supernatants removed and cells pellets were
washed once in PBS to remove unincorporated 32P. Radiolabeled cells were resuspended in 20µl of 50µg/ml lysostaphin in
10mM Tris pH 8.0 1mM EDTA for 10min at room temperature, Laemmeli sample buffer was added (without boiling), and
sample (total cell homogenate) was separated by SDS 7.5-15% PAGE. Gel was autoradiographed and density of bands
determined. Gel was then stained in coomassie to ensure that equal amounts of protein were in fact loaded on the gel.
For RAP/RIP or RAP/AIP competition experiments, 450µl cells in PFB and 32P prepared as described above were incubated
with 50µl RAP (40x >10) which was partially purified from post exponential supernatants (see above, preparation of RAP),
together with 50µl, 25µl, and 12.5µl native RIP or AIP (prepared as described above) and the volume adjusted to 550µl with
CY. This gave us an estimated RAP:RIP or RAP/AIP ratio of 1:1, 1:0.5 and 1.025.
7
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
Activation of RNAIII synthesis
Early exponential 6390B (450µl) were incubated with 50µl of the sample in question (prepared as described above: RAP,
AIP, total 10x, native RIP, CY or PBS) for 30min while shaking at 37oC. Cells were collected by centrifugation (2min
12,000xg) and RNA purified as described below. If cells were incubated with synthetic RIP, the amount peptide used was
10µg/4x106 cells.
Detection of RNAIII and TRAP transcript: RNA purification and northern blotting
Equal number of cells were resuspended in 50µl lysostaphin in TES buffer (200µg/ml lysostaphin (Sigma) in 100mM Tris pH
7.2, 1mM EDTA, 20% sucrose) and incubated for 10 minutes at room temperature. 50µl of 2% SDS containing Proteinase K
(100 µg/ml) was added and vigorously vortexed for 1 minute followed by 10min incubation at room temperature. The sample
was frozen and thawed twice. 15µl RNA sample was mixed with 11% deionized glyoxal, 16mM phosphate buffer pH 7.0 and
55% DMSO (final concentrations) and incubated for 1hr at 65oC. RNA loading buffer (Ambion) was added and sample (of
about 5x108 cells) applied to a 1% agarose gel in 10mM phosphate buffer pH 7.0 supplemented with 5mM Iodoacetic acid
(Sigma). Gel was northern blotted by dry transfer, membrane stained in methelene blue to view RNA and ensure that the
same amounts of RNA were transferred. Membrane was prehybridized using rapid-hyb (Amersham) followed by
hybridization with PCR radiolabeled RNAIII specific DNA (6), or with PCR radiolabeled 3’ trap (nt 400-550). Gels were
autoradiographed and intensity of band determined using quantitative analysis program (Molecular Analyst).
TRAP-P purification
Cell pellet of 500 ml early exponential S. aureus cells (grown as described above) was resuspended in 30 ml PFB, 560 µCi
32P and 3ml RAP, and grown for 1hr with shaking at 37oC. Cells were collected by centrifugation, washed in PBS, and
resuspended in 2.5ml of water containing 100µg/ml lysostaphin (Sigma) and incubated on ice for 20min. 7.5ml water were
added, and cells were further incubated on ice for 20min and cells disrupted by extensive sonication (Sonic Dismembrator,
Fisher Scientific, microtip probe) (3 times for 10 seconds each time on ice). Sonicated material was centrifuged (10min
12,000xg), and soluble material collected. Soluble material was concentrated by lyophilization (Savant, Speedvac Plus
8
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
SC110A) to 800µl. Material was fractionated on gel filtration HPLC column (Bio-Sil SEC-125 300x7.8mm, BioRad) in
1mM phosphate buffered saline pH 8.0 at a flow rate of 1ml/min. 1ml fractions were collected and tested for radioactivity in
a scintillation counter (Beckman, LS600 MultiPurpose Scintillation Counter). Samples containing high counts per min
(CPM) in comparison with the rest of the fractions were selected and separated by SDS 15% PAGE and gel
autoradiographed. The fraction containing the radiolableled 21kDa protein (phosphorylated TRAP) was used to further purify
TRAP by anion exchange chromatography (HPLC SynchroPak Q300, Keystone Scientific, Inc.) in 0.1x PBS pH 7.5. Bound
material was eluted by a salt gradient of 0-1M NaCl in 0.1x PBS pH 7.5. Fractions containing high CPM were separated by
SDS 15% PAGE and gel autoradiographed to determine the fraction-containing TRAP. Phosphorylated TRAP eluted at
0.75M NaCl. 21kDa radioactive band was cut and submitted for amino acid sequencing (see below).
Amino acid sequence analysis
Anion exchange TRAP-containing fraction was applied on SDS PAGE, the gel stained in coomassie and autoradographed.
Protein band corresponding with phosphorylation was cut and N-terminally sequenced or subjected to tryptic digest for
acquiring internal sequences. Specifically, gel was dried, rehydrated in 50mM ammonium bicarbonate pH 7.8 and incubated
with 0.5µg trypsin overnight at 37oC. Peptides were extracted by 70% acetonitrile/5% formic acid, and fractionated on a C18
HPLC (Vydac, 4.6x25) in 0.1% TFA. Peptides were eluted at a 115 min gradient of 0-70% acetonitrile. Peptides were
collected and amino acid sequenced commercially by Edman degradation chemistry (ABI 477 sequencer, Protein Structure
Laboratory, UC Davis). Sequences were compared to the S. aureus Genome Sequencing Project database and the sequence of
TRAP determined. Primers corresponding to the 5’ and the 3’ end of the gene were constructed, trap was amplified by PCR,
and DNA sequence confirmed.
Inactivation of trap
An internal 317bp fragment (#73- #390) of the trap gene was amplified by PCR using the following primers: 1. 5’-
CGCGCGGATCCCAACTATTCCAATTTTCAG - 3’ (containing BamHI site) and 2. 5’ -
CGCGAAGCTTCTTAAAGTCTTCGTATG-3’ (containing HindIII site). The amplified PCR fragment was cloned into the
BamHI/ HindIII sites of the pAUL-A vector (kindly provided by S. Del-Cardayre), which is a shuttle vector between S.
9
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
aureus and E. coli. This plasmid contains an erythromycin resistance marker and carries a temperature sensitive mutation at
the S. aureus origin of replication, and therefore is capable of replication in S. aureus cells only in the permissive temperature
of 30oC. S. aureus strain RN4220 cells (a restriction deficient derivative of strain 8325-4 which is therefore capable of
accepting foreign DNA (21) were transformed with the above construct by electroporation as described (22), and
transformants were grown on NYE agar (23) in the presence of 10µg/ml erythromycin in the permissive temperature of 30oC
over night. Transformants were grown on NYE agar in the presence of 10µg/ml erythromycin in the restrictive temperature of
42oC over night. Colonies were analyzed for integration of the plasmid into the chromosome at the trap site via a Campbell
insertion process. The analysis was done by PCR, employing primers that are homologous to the plasmid region (universal
reverse primer 5’ GTAAAACGACGGCCAGT 3’) and absent in the chromosome, and a primer that is homologous to the
pre- 5’ end of the trap gene and is not present on the plasmid construct (5’ GTGGTAATGACTAGTTTATCATCGT 3’ (nt
–59 to –34). A DNA fragment of 500 bp was generated using the above primers, indicating the integration of the plasmid and
disruption of trap.
Phosphoamino acid analysis
Purified radiolabeled TRAP-P was applied to SDS-PAGE. Slices of acrylamide, containing labeled TRAP-P, were excised
and submerged in 3 N KOH at 105 °C for 5 h. Resulting hydrolysate was diluted 25-fold with water containing internal
standards of phosphoserine and phosphotyrosine. Phosphoamino acids were separated by ion-exchange chromatography
(24). O-Phthalaldehyde was added to the eluate, and the resulting fluorescence was detected on-line (24). Radioactivity was
quantified by liquid scintillation counting. Phospholysine and phosphohistidine were synthesized as described previously
(24). All other standards were purchased from Sigma. In this system, phosphoarginine and phospholysine elute before
phosphoserine, phosphothreonine elutes close to phosphoserine, and phosphohistidine elutes between phosphoserine and
phosphotyrosine (24).
10
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
RESULTS
RAP activates and RIP inhibits RNAIII synthesis and the phosphorylation of a 21kDa protein
Early exponential wild type S. aureus cells were incubated for 40min in the presence of RAP, synthetic RIP (Genemed
Synthesis, Inc. CA), or with PBS only as a control. Cells were collected, RNA purified, northern blotted, and membranes
incubated with radiolabeled RNAIII specific DNA as a probe. As previously demonstrated (14, 16) and as shown in Fig. 1,
RAP activates and RIP inhibits RNAIII synthesis. The pathway by which the autoinducer RAP activates and the peptide RIP
inhibits RNAIII synthesis was not known, but it was hypothesized that RAP and RIP interact with the same receptor, one as
an agonist (RAP), the other as an antagonist (RIP). Therefore, it seemed reasonable to assume that like other quorum sensing
molecules, they would regulate a bacterial two component system by phosphorylation (25). To identify the signal
transduction pathway regulated by RAP and RIP, in vivo phosphorylation assays were performed. Early exponential wild
type S. aureus were incubated in phosphate free buffer supplemented with radiolabeled orthophosphate, together with RAP in
PBS, with PBS, or with RIP (native or synthetic). After a 40min incubation period, the cells were collected by centrifugation,
treated with lysostaphin, followed by the addition of sample buffer, and without boiling, total cell homogenate was applied to
both 7.5 % and 15% SDS PAGE and the gel stained in coomassie or autoradiographed. As shown in Fig. 2, RAP activates
and RIP inhibits the specific phosphorylation of a 21kDa protein which we termed TRAP. Endogenous RAP is produced as
the cells grow (14), probably contributing to the positive signal in the control PBS group (Fig. 2 lane 1). To determine if RIP
competes with RAP on TRAP phosphorylation, cells were incubated with RAP together with increasing amounts of native
RIP (at RAP:RIP ratio of: 1:1, 1:0.5, and 1:0.25), and in vivo phosphorylation assays were carried out. As demonstrated in
Fig. 3, the higher the amount of RIP present, the lower the amount of TRAP phosphorylation, suggesting that RIP competes
with RAP on the phosphorylation of TRAP.
To determine whether RAP induces the synthesis of TRAP and not only its phosphorylation, the in vivo phosphorylation
assays were carried out in the presence of 100µg/ml chloramphenicol (Cm), to inhibit potential translation processes. The
results of these experiments (not shown) indicate that RAP activates TRAP phosphorylation also in the presence of Cm,
suggesting that RAP activates TRAP phosphorylation and not synthesis.
Structure of TRAP
11
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
To purify TRAP, wild type early exponential S. aureus cells were in vivo phosphorylated, cells were disrupted by extensive
sonication, and soluble material containing phosphorylated TRAP (TRAP-P) was fractionated on an HPLC gel filtration
column. Positive fractions (determined by peak radioactivity and confirmed by separating a sample on SDS PAGE) were
applied to an HPLC anion exchange column and bound material was eluted by a 0-1M NaCl gradient. Positive fraction
containing TRAP-P eluted at approximately 0.75M NaCl.
To determine the amino acid sequence of TRAP, purified TRAP was internally digested by trypsin, and peptide digests were
amino acid sequenced. Acquired sequences were compared to the S. aureus database and the sequence of TRAP was
determined to be a 167 amino acid polypeptide (Fig. 4) (GenBank accession number for nucleotide sequence: BankIt301902
AF202641). The sequence of TRAP (Fig. 4 A,B) is unique to S. aureus and shows no significant sequence homologies to
known proteins or genes but for 5’ end of the Bacillus subtilis penicillin-binding protein gene (pbpF), with which it shares
28% identity (26). 2D proton NMR spectra (not shown) reveal a folded protein made up of both α-helices and β-sheet
secondary structure elements, in agreement with sequence and threading analysis (Fig. 4C) generated by the PHD package
(27).
RAP does not activate RNAIII synthesis in the trap mutant strain
The trap gene was inactivated by gene disruption. An internal 317bp fragment of the trap gene lacking regions of about 100
bp from the 5’ and the 3’ ends of the gene was cloned into pAUL (Fig. 5A), a temperature sensitive shuttle vector (kindly
provided by S. Del Cardayre), and plasmid used to transform S. aureus RN4220 cells. Transformants were analyzed for
integration of the plasmid into the chromosome at the trap site via a Campbell insertion process. The analysis was done by
PCR, employing primers that are homologous to the vector and to the 5’ sequences of the pre-trap gene not present on the
plasmid construct. A DNA fragment of about 500 bp was generated, indicating the integration of the plasmid and the
disruption of trap, resulting in a trap– mutant strain (S. aureus OU20). Sequence analysis of OU20 indicated the replacement
of the 3’ end of the trap gene (from nt 390) with pAUL DNA. S. aureus OU20 was in vivo phosphorylated in the presence of
RAP, and total cell homogenate applied to SDS PAGE, and TRAP-P detected by autoradiography. As shown in Fig. 5B,
while RAP activated the phosphorylation of TRAP in the trap+ strain (lane 1), it did not activate phosphorylation in the trap–
12
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
OU20 strain (lane 2), suggesting that in fact the trap gene was disrupted.
To test whether RAP activates the synthesis of RNAIII via TRAP, early exponential S. aureus trap+ and trap– cells were
incubated together with RAP, and after 40min cells were collected, RNA extracted, and RNAIII was analyzed by northern
blotting, using radiolabeled RNAIII specific DNA as a probe. As shown in Fig. 5C, while RNAIII synthesis was activated by
RAP in the parent trap+ strain, it was not activated in the trap– strain, suggesting that the presence of an intact trap gene is
necessary for RAP to activate RNAIII synthesis. To test whether RNAIII can be synthesized in the absence of TRAP during
bacterial growth, trap+ and trap– cells were grown for several hours from the early exponential phase of growth, and RNAIII
and TRAP tested by northern blotting. As shown in Fig. 5D, RNAIII synthesis was greatly reduced in the trap– mutant strain,
but was not abolished. These results suggest that trap is important for the activation of RNAIII synthesis, but that the
synthesis of RNAIII can never the less be activated at a later stage in the absence of TRAP, possibly by alternate pathways
such as sar (28,29). As also shown in Fig. 5D, trap transcription is in fact absent in the trap– strain, and is constitutive in the
trap+ strain. Of note is the fact that the translation of TRAP also appears to be constitutive in the wild type trap+ strain (data
not shown). The fact that trap is constitutively transcribed and translated while its phosphorylation is regulated, further
supports out results indicating that RAP regulates TRAP phosphorylation and not synthesis.
TRAP is histidine phosphorylated
Two-component systems act through phosphorylation of the substrate domain of the sensor protein and subsequent transfer
of the phosphate to an aspartate residue in the regulator protein. The initial phosphorylation is catalyzed by a protein histidine
kinase domain in the sensor protein and results in an N-phosphorylated histidine residue, which is stable in alkaline
conditions but not in acidic conditions (24).
To test whether TRAP may be histidine-phosphorylated, we tested the sensitivity of phosphorylated TRAP to acidic and
basic conditions. Phosphorylated TRAP was incubated in pH ranging from 1-10, for 10 min at room temperature. The
mixture was then applied to SDS PAGE and the gel autoradiographed. As shown in Fig. 6A, phosphorylation of TRAP was
13
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
found to be stable at pH greater than 8.0 but labile in lower pHs, consistent with a possible N phosphorylation of a histidine.
Phosphoamino acid analysis indicates that in fact TRAP-P contains phosphohistidine. Purified radiolabeled TRAP-P was
applied to SDS PAGE. Gel band containing TRAP-P was subjected to alkaline hydrolysis followed by chromatography (24).
The labeled phosphoamino acid eluted at the position of phosphohistidine, which is distinct from phosphoarginine,
phospholysine, phosphothreonine, phosphoserine or phosphotyrosine (Fig. 6B). Histidine phosphorylation indicates that
TRAP may in fact be a sensor of RAP.
Regulation of TRAP phosphorylation
RNAIII is produced only from mid exponential phase of growth, while TRAP is continuously transcribed (Fig. 5D). If RAP
activates RNAIII via TRAP phosphorylation, it seemed reasonable to assume that TRAP phosphorylation and RNAIII
synthesis should be coupled. To determine when TRAP is phosphorylated during bacterial growth, wild type S. aureus were
grown from early to late logarithmic phase of growth in the presence of 32P. Cells were collected at time intervals, and
assayed both for TRAP phosphorylation and for RNAIII synthesis. As shown in Fig. 7A,B, peak phosphorylation of TRAP is
reached at the mid exponential phase of growth. Peak phosphorylation of TRAP directly correlates with RNAIII synthesis,
supporting our hypothesis that RAP regulates RNAIII synthesis via TRAP phosphorylation.
As shown in Fig. 7A,B, TRAP reaches its peak phosphorylation by mid exponential phase of growth, but is dephosphorylated
by late logarithmic phase of growth. The RNAIII gene, on the other hand, once activated, remains upregulated throughout
growth (Fig. 7B). The fact that TRAP is dephosphorylated by late log indicates that TRAP phosphorylation is necessary only
for the induction of the RNAIII gene but not for its ongoing transcription.
AIP activates RNAIII synthesis but inhibits TRAP phosphorylation
RNAIII production has been shown to be autoinduced also by AIP, an octapeptide encoded by the agr itself. AIP activates
RNAIII synthesis by activating a two component system, also encoded by the agr. Specifically, once the agr is activated in
the mid exponential phase of growth, an octapeptide is produced (processed from AgrD), inducing the phosphorylation of a
46kDa protein AgrC (11), hypothesized to phosphorylate AgrA (12), leading to upregulation of RNAIII synthesis. To
14
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
determine the interaction of the agr and the TRAP signal transduction systems, we tested whether TRAP can be
phosphorylated also in an agr-null strain.
An agr-null S. aureus strain RN6911 (a mutant strain that contains a tetM gene instead of agr (6)) was grown from early to
late logarithmic phase of growth in the presence of 32P. Cells were collected at time intervals, applied on SDS PAGE and
autoradiographed. As shown in Fig. 7C, TRAP is phosphorylated also in the agr-null strain. Like in the wild type, peak
phosphorylation is reached at the mid exponential phase of growth. However, unlike in the wild type strain, TRAP was not
dephosphorylated by the late logarithmic phase of growth, suggesting that the agr itself, once activated in the mid exponential
phase, produces a factor which down regulates TRAP phosphorylation.
To determine if AIP is the dephosphorylating, agr-encoded factor, we incubated wild type cells with AIP, with RAP, or with
culture supernatants containing both RAP and AIP in a RAP:AIP ration of 20:80 (16). TRAP phosphorylation was tested by
in vivo phosphorylation assays, and RNAIII synthesis was tested by northern blotting. As shown in Fig. 8A,B, while RAP
activates RNAIII synthesis and activates TRAP phosphorylation, AIP activates RNAIII synthesis but inhibits TRAP
phosphorylation.
To test if AIP competes with RAP on TRAP phosphorylation, cells were grown in the presence of RAP together with
increasing amounts of AIP. As shown in Fig. 8C, the level of TRAP-P is dependent on the ratio between the two
autoinducers. The more AIP in the culture supernatant as compared to RAP, the less TRAP phosphorylation occurred. These
results can explain why TRAP is dephosphorylated from the mid exponential phase of growth, which is when agr is
activated, and when AIP is produced.
RAP and AIP activate RNAIII synthesis via different signal transduction pathways
RAP does not activate RNAIII synthesis in a trap– strains (Fig. 5C), suggesting that RAP activates RNAIII via TRAP
phosphorylation. To test whether AIP and RAP activate RNAIII synthesis by interacting with the same signal transduction
pathway, we tested whether AIP can activate RNAIII synthesis in a trap– strain. trap+ and trap– strains were grown in the
presence of RAP or AIP and tested for RNAIII synthesis. As shown in Fig. 8D, RAP did not activate RNAIII in the trap –
15
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
strain, while AIP activates RNAIII synthesis both in the trap+ and trap – strain. These results suggest that AIP does not
activate RNAIII via TRAP and that RAP and AIP activate RNAIII synthesis via different signal transduction pathways.
While AIP activates RNAIII synthesis via the agr system (phosphorylation of AgrC (11)), RAP activates RNAIII synthesis
via the TRAP system (phosphorylation of TRAP).
16
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
DISCUSSION
Our work demonstrates that the autoinducer of virulence RAP activates and the inhibitor of virulence RIP inhibits the
phosphorylation of a 21kDa protein termed TRAP. Amino acid sequence analysis of TRAP indicates that the 167 amino acid
polypeptide is unique to S. aureus. RAP does not activate RNAIII synthesis in a S. aureus strain containing a disrupted trap,
suggesting that an intact trap gene is necessary for the activation of RNAIII synthesis by RAP. Phosphoamino acid analysis
of TRAP-P indicates that TRAP is histidine phosphorylated, indicating that TRAP may be a sensor of RAP. Secondary
structure predictions suggest it, however, to be globular α-helix β-sheet protein, that does not have a trans- membrane
region that is classical for a histidine kinase. TRAP may therefore either be part of a non-classical histidine kinase (30), or
bound to a yet to be identified, membrane associated molecule (Figure 9).
TRAP reaches its peak phosphorylation by mid exponential phase of growth, but is dephosphorylated by late logarithmic
phase of growth. The gene for RNAIII, on the other hand, once activated, remains upregulated throughout. The fact that
TRAP is dephosphorylated by late log indicates that TRAP phosphorylation is necessary only for the induction of the RNAIII
gene but not for its ongoing transcription.
TRAP is phosphorylated also in the agr-null strain. Like in the wild type, peak phosphorylation is reached at mid exponential
phase of growth. However, unlike in the wild type strain, TRAP is not dephosphorylated by late log, suggesting that the agr
itself, once activated in the mid exponential phase, produces, or regulates the production of, a factor, which down regulates
TRAP phosphorylation.
One of the factors produced by the agr is the octapeptide AIP that also activates RNAIII synthesis. However, the agr locus is
temporally regulated, and therefore the AIP is only produced from mid exponential phase of growth (17). We show here that
while RAP activates RNAIII synthesis as well as TRAP phosphorylation, the AIP activates RNAIII synthesis but inhibits
TRAP phosphorylation. Furthermore, while RAP does not activate RNAIII synthesis in a trap– strain, AIP does upregulate
RNAIII synthesis in a trap– strain, suggesting that RAP and AIP activate RNAIII synthesis via different signal transduction
pathways. The fact that TRAP phosphorylation is downregulated in the presence of the AIP may explain why TRAP is
17
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
dephosphorylated at mid exponential phase of growth, coinciding with AIP production. The interplay between the two signal
transduction pathways suggests that TRAP and the agr gene products could be part of a phosphorelay system. The
phosphorelay is an extended and more complex version of the two component system, involving multiple activation signals
processed by at least two histidine kinases (30,31). We propose that while RAP (signal A) activates the TRAP signal
transduction (kinase A), the AIP (signal B) activates the agr system (kinase B), which probably leads to activation of a
phosphatase and to the dephosphorylation of TRAP (Figure 9).
It has been suggested that RNAIII synthesis is only regulated by the peptides encoded by the agr (AIPs) and that RIP is part
of the AIP family of peptides (19). While this may be the case, several experimental data do not support this hypothesis (16).
1. AIPs must contain a thiolactone structure to be active while the RIP peptides are synthesized without a cysteine and a
thiolactone structure and are active as linear peptides. 2. Both RIP and AIP of self inhibit TRAP phosphorylation, but while
RIP inhibits RNAIII synthesis, AIP of self activates RNAIII synthesis. 3. AIP activates RNAIII synthesis in a trap– strain
while RAP does not, suggesting that AIP and RAP activate RNAIII synthesis via different signal transduction pathways.
Furthermore, RIP prevents infections cause by various strains of S. aureus in different infection models, suggesting that unlike
the AIPs, RIP is not strain specific in its inhibitory activity.
In summary, we propose (Figure 9) that autoinduction of virulence occurs in a two step process. As the colony multiplies, the
autoinducer RAP accumulates and induces the phosphorylation of its target molecule TRAP, resulting in upregulation of agr
to produce RNAII (Balaban et al., unpublished). Once agr is activated (in the mid exponential phase of growth), AIP and its
receptor AgrC are produced. AIP upregulates the phosphorylation of its receptor, AgrC (11), leading to phosphorylation of
AgrA, to upregulation of RNAIII synthesis (9) and to down regulation of TRAP phosphorylation . Production of RNAIII, in
parallel with upregulation of sar (32) and sae (33), causes the expression of toxic exomolecules and the suppression of
adhesion molecules, resulting in dissemination and in disease. In the presence of anti-RAP antibodies, RIP or inhibitory
AIPs, RNAIII is not produced, and the pathogenic potential of the bacteria is greatly reduced (10, 15, 16, 20).
18
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
ACKNOWLEDGMENTS
We thank Andrea Carbone, UC Davis for her assistance in phosphoamino acid analysis, Dr. Ilya Borovok for helpful
discussions, and Prof. Gerald Cohen and Prof. Yair Aharonowitz for their generosity. We thank S. Del-Cardayre, for kindly
providing the pAUL-A plasmid. We thank Dr. Young Moo Lee and Tara Martinez, Protein Structure Laboratory, UC Davis,
for their assistance in resolving the amino acid sequence of TRAP. We thank B.A. Roe, Yudong Qian, A. Dorman, F. Z.
Najar, S. Clifton and J. Iandolo, University of Oklahoma, who, with funding from the NIH and the Merck Genome Research
Institute, are carrying out the S. aureus Genome Sequencing Project. This project was supported by UCDHSRA, InterMune
Pharmaceuticals, AHA, and CTR.
19
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
REFERENCES
1. Lowy, F.D. (1998). New England Journal of Medicine 339, 520-532.
2. Abdelnour, A., Arvidson, S., Bremell, T., Ryden, C. and Tarkowski, A. (1993). Infect Immun. 61, 3879-3885.
3. Moreau, J. M., G. M. Sloop, L. S. Engel, J. M. Hill, and R. J. O’Callaghan. (1997). Curr. Eye. Res. 16, 1221-1228.
4. Gillaspy, A.F., Hickmon, S.G., Skinner, R.A., Thomas, J.R., Nelson, C.L. and Smeltzer, M.S. (1995). Infect Immun. 63,
3373-3380
5. Schmitt, C.K., Meysick, K.C. and O’Brien, A.D. (1999). Emerg Infect Dis. 5, 224-234.
6. Novick, R.P., Ross, H.F., Projan, S.J., Kornblum, J., Kreiswirth, B. and Moghazeh, S. (1993). EMBO J. 12, 3967-3975.
7. Balaban, N. and Novick, R.P. (1995). FEMS Microbiol. Letts. 133, 155-161.
8. Moerfeldt, E., Taylor, D., Von Gabain, A. and Arvidson, S. (1995). EMBO J. 14, 4569-4577.
9. Novick, R.P., Projan, S.J., Kornblum, J., Ross, H.F., Ji, G., Kreiswirth, B., Vandenesch, F. and Moghazeh, S. (1995). Mol
Gen Genet. 248, 446-458.
10. Mayville, P., Ji, G., Beavis, R., Yang, H., Goger, M., Novick, R.P. and Muir, T. (1999). Proc Natl Acad Sci USA 96,
1218-1223.
11. Lina, G., Jarraud, S., Ji, G., Greenland, T., Pedraza, A., Etienne, J., Novick, R.P. and Vandenesch, F. (1998). Mol
Microbiol. 28, 655-662.
12. Morfeldt, E., Panova-Sapundjieva, I., Gustafsson, B. and Arvidson, S. (1996). FEMS Microbiol Lett 143, 195-201.
13. Kleerebezem, M., Quadri, L.E., Kuipers, O.P. and de Vos, W.M. (1997). Mol Microbiol. 24, 895-904.
14. Balaban, N. and Novick, R.P. (1995). Proc. Natl. Acad. Sci. USA 92, 1619-1623.
15. Balaban, N., Goldkorn, T., Nhan, R.T., Dang, L.B., Scott, S., Ridgley, R.M., Rasooly, A., Wright, S.C., Larrick, J.W.,
Rasooly, R. and Carlson, J.R. (1998). Science 280, 438-40.
20
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
16. Balaban, N. Singh, B., Goldkorn, R.T. Rasooly, A. Torres, J.V. and Uziel, O. (2000). Science 287, 391a.
17. Ji, G., Beavis, R. and Novick, R.P. (1995). Proc. Natl. Acad. Sci. 92, 12055-12059.
18. Ji, G., Beavis, R. and Novick, R.P. (1997). Science. 276, 2027-2030.
19. Novick, R.P., Ross, H.F., Figueiredo A.M.S., Abramochkin, G. and Muir T. (2000). Science 287, 391a.
20. Balaban, N., Cullor, J.S., Hume, E.B., Medina-Acosta, E., Vieira da Motta, O., O’Callaghan, R., Rossitto, P.V., Shirtliff,
M.E., Serafim da Silveira L. and Torres, J.V. (2000). Peptides. In Press.
21. Novick, R.P. (1991). Methods Enzymol. 204, 587-636.
22. Schenk, S. and Laddaga, R. A. (1992). FEMS Microbiol. Lett. 94, 133-138.
23. Lee, C. Y., Buranen, S. L., and Ye, Z. H. 1991. Gene 103, 101- 105.
24. Wei, Y.F. and Matthews, H.R. (1991). Methods Enzymol. 200, 388-414.
25. Russo, F.D. and Silhavy, T.J. (1993). Trends Microbiol. 1, 306-310.
26. Popham, D.L. and Setlow, P. (1993). J. Bacteriol. 175,4870-4876.
27. Rost, B. and Sander, C. (1993). J. Mol Biol. 232, 584-599.
28. Cheung, A.L., Bayer, M.G., Heinrichs, J.H. (1997). J Bacteriol 179, 3963-3971.
29. Chien, Y. and Cheung, A.L. 1998. .J. Biol Chem . 273, 2645-2652.
30. Perraud, A.L., Weiss, V. and Gross, R. (1999). Trends Microbiol. 7, 115-120.
31. Tzeng, Y.L., Feher, V.A., Cavanagh, J., Perego, M. and Hoch, J.A. (1998). Biochemistry, 37, 16538 –16545.
32. Bayer, M.G., Heinrichs, J.H. and Cheung, A.L. (1996). J Bacteriol. 178, 4563-4570.
33. Giraudo A.T., Calzolari A., Cataldi A.A., Bogni C., Nagel R. (1999). FEMS Microbiol Lett. 177, 15-22.
21
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
FIGURE LEGENDS
Fig. 1. RNAIII synthesis is activated by RAP and inhibited by RIP.
Early exponential S. aureus cells were incubated for 40 min together with synthetic RIP (lane 1), with PBS as a control (lane
2) or with RAP (lane 3) as described in the methods section “Activation of RNAIII synthesis”. RNA was purified, and equal
amount of RNA were applied to the gel and the gel was northern blotted. RNAIII was detected using radiolabeled RNAIII
specific DNA as a probe. Membrane was autoradiographed and density of bands determined.
Fig. 2. The phosphorylation of TRAP is activated by RAP and inhibited by RIP.
Wild type early exponential S. aureus cells were in vivo phosphorylated in the presence of PBS only as a control (lane 1),
synthetic RIP (lane 2), or RAP (lane 3). Cells were collected, and total cell homogenate applied to 15% SDS PAGE (A,C) or
to 7.5% SDS PAGE (B). The gel was coomassie stained (A) or autoradiographed (B,C). Approximate molecular weight is
indicated in kDa.
Fig. 3. RIP competes with RAP of TRAP phosphorylation.
In vivo phosphorylation: RAP/RIP competition experiment. Wild type early exponential cells in PFB and 32P (450µl) were
incubated with 50µl RAP (>10) which was partially purified from post exponential supernatants (lane 1), with PBS as a
control (lane 2), with 50µl native RIP (lane 3) or with 50µl partially purified RAP (>10) together with 50µl, 25µl, and 12.5µl
native RIP, and the total volume adjusted to 550µl with CY (lanes 4-6). This gave an estimated RAP:RIP ratio of 1:1 (lane
4), 1:0.5 (lane 5) and 1:0.025 (lane 6). After 60 min cells were collected, and total cell homogenate applied to SDS PAGE
and gel autoradiographed.
Fig. 4 A,B. Amino acid sequence of TRAP (A) and DNA sequence of trap (B).
Fig. 4C. Secondary Structure Prediction (SSP) of TRAP generated by the PHD package (27). Cylinders and arrows denote
α-helix and β-sheet, respectively.
22
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
Fig. 5A. pAUL-A containing trap nt 73-390.
Fig. 5B. In vivo phosphorylation of S. aureus containing a disrupted trap gene. Early exponential S. aureus trap and trap+
cells were in vivo phosphorylated in the presence of RAP. After 40min cells were collected, total cell homogenate applied to
SDS PAGE, and the gel autoradiographed. Lane 1: trap+. Lane 2. trap–.
Fig. 5C. The synthesis of RNAIII is not activated by RAP in the trap mutant strain. Early exponential S. aureus trap– and
trap+ cells were incubated for 40 min with PBS (RAP –) or with RAP (RAP +). RNA purified, and equal amount of RNA (10µg)
applied to the gel and the gel was northern blotted. RNAIII was detected using radiolabeled RNAIII specific DNA as a probe,
and membrane was autoradiographed.
Fig. 5D. The production of RNAIII is reduced in the trap– strain. Early exponential (1x109 cells/ml) S. aureus trap– and
trap+ cells were grown for one to four hours. Equal number of cells collected, RNA extracted, and RNAIII and TRAP transcript
tested by northern blotting and the membrane autoradiographed. Lane 1-4. Cells grown for 1-4 hrs respectively.
Fig. 6A. TRAP-P is stable in alkaline conditions. Phosphorylated TRAP was incubated for 10min at room temperature in
increasing pHs, applied on SDS PAGE, autoradiographed, and density of bands determined. Results are presented as % of
maximum phosphorylation observed (% of max).
Fig. 6B. TRAP-P contains phosphohistidine. An alkaline hydrolysate of radiolabeled TRAP-P was analyzed by
chromatography. The labeled phosphoamino acid eluted at the position of phosphohistidine (P-His), distinct from
phosphoarginine, phospholysine, phosphothreonine, phosphoserine (P-Ser) or phosphotyrosine (P-Tyr).
Fig. 7A,B. TRAP reaches peak phosphorylation at the mid exponential phase of growth: Wild type S. aureus were grown
from early to late log phase of growth in PFB together with 32P. Cells were collected at time intervals, and tested both for
23
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
RNAIII (by northern blotting) and for TRAP phosphorylation (by SDS PAGE). A. Cells were resuspended in sample buffer
and were applied to SDS 15% PAGE and the gel autoradiographed. Approximate molecular weight is indicated in kDa. B.
TRAP phosphorylation vs. RNAIII and cell #. Results are presented as % of maximum phosphorylation, RNAIII, or cell
number observed (% of max).
Fig. 7C. TRAP is phosphorylated in agr-null strains. Mutant agr-null S. aureus cells RN6911 were grown from early to late
log phase of growth in PFB together with 32P. Cells were collected, and total cell homogenate applied to SDS PAGE, and the
gel autoradiographed.
Fig. 8A,B,C. The phosphorylation of TRAP is activated by RAP and inhibited by AIP. A. Wild type early exponential S.
aureus cells were incubated for 1 hr in PFB, 32P, together with RAP (40x, >10) containing no AIP, with post exponential
total supernatant (total, containing 20% RAP and 80% AIP (16, 19)), with AIP (containing no RAP), or with PBS as a
control. Cells were collected, applied to SDS PAGE, and the gel autoradiographed. The autoradiogram was scanned and the
density of the bands determined.
B. In parallel, cells (in CY) were incubated in the presence of RAP, PBS, AIP and total supernatant for 40min and cells
assayed for RNAIII by northern blotting. Density of bands determined and results are presented as % of maximum RNAIII
observed (% of max).
C. In vivo phosphorylation: RAP/AIP competition experiment. Wild type early exponential cells in PFB and 32P (450µl)
were incubated with 50µl RAP (40x >10) which was partially purified from post exponential supernatants (lane 1), together
with 25µl AIP and 25µl CY (lane 2), or together with 50µl AIP (lane 3). This gave an estimated RAP:AIP ratio of 1:0 (lane
1), 1:0.5 (lane 2), and 1:1 (lane 3). After 40 min cells were collected, applied to SDS PAGE and gel autoradiographed and
density of bands determined (C).
Fig. 8D. RNAIII synthesis is activated by AIP but not by RAP in a trap mutant strain. Early exponential (1x109 cells/ml) S.
aureus trap– and trap+ cells were grown for 40min in the presence of RAP, PBS or AIP. Equal number of cells collected,
24
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
RNA extracted, and RNAIII tested by northern blotting and the membrane autoradiographed.
Fig. 9. Interaction of TRAP and AgrC. As the colony multiplies, the autoinducer RAP accumulates and induces the
phosphorylation of its target molecule TRAP (A), resulting in the production of RNAII (B). Once agr is activated (in the mid
exponential phase of growth), AIP and its receptor AgrC are produced (9). AIP downregulates TRAP phosphorylation and
upregulates the phosphorylation of its receptor, AgrC (B) (11), which is hypothesized to phosphorylate AgrA (C), which then
acts as a transcription activator to activate P3 (12), leading to the production of RNAIII. Production of RNAIII, in parallel
with upregulation of sar and sae, causes the expression of toxic exomolecules and the suppression of adhesion molecules (C)
(6, 32, 33), resulting in dissemination and in disease. RAP; RNAIII activating protein. AIP; autoinducing peptide. TRAP;
target of RAP.
25
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
by guest on March 31, 2020 http://www.jbc.org/ Downloaded from
Matthews, Rachael T. Nhan, Baljit Singh and Orit UzielNaomi Balaban, Tzipora Goldkorn, Yael Gov, Miriam Hirshberg, Nir Koyfman, Harry R.
Regulation of S. aureus pathogenesis via TRAP
published online October 16, 2000J. Biol. Chem.
10.1074/jbc.M005446200Access the most updated version of this article at doi:
Alerts:
When a correction for this article is posted•
When this article is cited•
to choose from all of JBC's e-mail alertsClick here
by guest on March 31, 2020
http://ww
w.jbc.org/
Dow
nloaded from
Additions and Corrections
Vol. 276 (2001) 2658–2667
Regulation of Staphylococcus aureus pathogenesis viatarget of RNAIII-activating protein (TRAP).
Naomi Balaban, Tzipora Goldkorn, Yael Gov, MiriamHirshberg, Nir Koyfman, Harry R. Matthews, Rachael T. Nhan,Baljit Singh, and Orit Uziel
Page 2658, top right: The DOI of the Paper in Press (PIP) asshown on the print version is in error. The DOI should read:10.1074/jbc.M005446200.
Page 2658, right column: The GenBank™ accession numberappeared in the PIP version but was deleted in the final print/on-line version. The sentence ending 5 lines from the bottom ofthe page should read: NH2-terminal sequence IKKYKPITN(GenBank™ accession number AF205220) (16).
Vol. 276 (2001) 8904–8909
Dinucleotides as growth-promoting extracellularymediators. Presence of dinucleoside diphosphates Ap2A,Ap2G, and Gp2G in releasable granules of platelets.
Joachim Jankowski, Joost Hagemann, Martin Tepel, Markusvan der Giet, Nina Stephan, Lars Henning, Ioanna Gouni-Berthold, Agapios Sachinidis, Walter Zidek, and HartmutSchluter
Dr. Gouni-Berthold’s name was printed incorrectly. Thecorrected version is shown above.
Vol. 275 (2000) 20814–20821
The high resolution crystal structure of yeast hexo-kinase PII with the correct primary sequence providesnew insights into its mechanism of action.
Paula R. Kuser, Sandra Krauchenco, Octavio A. C. Antunes,and Igor Polikarpov
The Protein Data Bank accession numbers for the structuresincluded in this paper were omitted. The PDB code is 1IG8 andthe RCSB code is RCSB013246.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 23, Issue of June 8, pp. 20803–20804, 2001© 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
We suggest that subscribers photocopy these corrections and insert the photocopies at the appropriateplaces where the article to be corrected originally appeared. Authors are urged to introduce thesecorrections into any reprints they distribute. Secondary (abstract) services are urged to carry notice ofthese corrections as prominently as they carried the original abstracts.
20803
FIG. 9. Intracellular distribution ofnascent apoB-containing lipopro-teins in microsomal lumen of con-trol and fructose-fed hepatocytes.Cultured primary hamster hepatocyteswere pulsed for 45 min with [35S]methi-onine, and the radioactivity was chasedfor 0 or 1 h. Labeled cells were thensubjected to homogenization and frac-tionation of microsomes. Luminal li-poproteins were extracted from micro-somes by carbonate treatment and wereseparated from the membrane fractionby centrifugation followed by fraction-ation on a sucrose-gradient. After cen-trifugation, gradient fractions were col-lected and immunoprecipitated with ananti-hamster apoB antibody. Immunopre-cipitates were analyzed by SDS-PAGEand fluorography, and apoB radioactivitywas quantitated by cutting and scintilla-tion counting of the apoB-100 band. A,luminal lipoproteins in control hepato-cytes at 0 and 1 h chase; B, luminal li-poproteins in fructose-fed hepatocytes at0 and 1 h chase.
Vol. 275 (2000) 8416–8425
Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhancedlipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transferprotein in a fructose-fed hamster model.
Changiz Taghibiglou, Andre Carpentier, Stephen C. Van Iderstine, Biao Chen, Debbie Rudy, Andrea Aiton, Gary F. Lewis, andKhosrow Adeli
Page 8423, Fig. 9: The wrong figure was published although the legend is correct. The correct figure is shown below.
Data Interpretation: The interpretation of the data in Fig. 9 does not significantly change with this correction. However, animportant observation also reported previously should be emphasized further. As observed in the corrected Fig. 9, microsomesfrom control cells had a significant amount of dense apoB-containing lipoproteins (HDL density), at both 0 and 1 h, which wereabsent in hepatocytes from fructose-fed hamsters. The absence of HDL-dense apoB particles suggests the stimulated state ofVLDL assembly and secretion in hepatocytes of fructose-fed hamsters.
Additions and Corrections20804
Additions and Corrections
Vol. 276 (2001) 1850–1856
Alkaline response genes of Saccharomyces cerevisiaeand their relationship to the RIM101 pathway.
Teresa M. Lamb, Wenjie Xu, Aviva Diamond, and Aaron P.Mitchell
Pages 1853 and 1854: We reported in Tables IV and V that avma4-lacZ fusion gene showed alkaline-induced, Rim101p-dependent expression. Subsequent analysis showed that thesestrains carried an arn4-lacZ fusion gene rather than the vma4-lacZ fusion gene. Therefore, our conclusion that VMA4 expres-sion responds to pH and to Rim101p is in error.
Vol. 276 (2001) 2658–2667
Regulation of Staphylococcus aureus pathogenesis viatarget of RNAIII-activating protein (TRAP).
Naomi Balaban, Tzipora Goldkorn, Yael Gov, MiriamHirshberg, Nir Koyfman, Harry R. Matthews, Rachael T. Nhan,Baljit Singh, and Orit Uziel
Page 2661: The left column, line 8 from the bottom, shouldread: “ . . . universal reverse primer 59-AACAGCTATGACC-ATG-39.”
Page 2662, Fig. 5: The arrow of Ery is drawn backward.Instead of pointing clockwise, it should point counterclockwise.
These changes do not affect the conclusions of the paper.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 15, Issue of April 13, p. 12476, 2001© 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
We suggest that subscribers photocopy these corrections and insert the photocopies at the appropriateplaces where the article to be corrected originally appeared. Authors are urged to introduce thesecorrections into any reprints they distribute. Secondary (abstract) services are urged to carry notice ofthese corrections as prominently as they carried the original abstracts.
12476